Net Asset Value(s)

MKTUPDTE

Thu, Apr 15 2021 08:30 am

Templeton Emerging Markets Investment Trust PLC ("TEMIT")

On behalf of TEMIT, Franklin Templeton International Services S.a.r.l. reports the unaudited cum-income net asset value ("NAV") of TEMIT as at
13 April 2021 was £2610.500m, representing a NAV of 1104.99 pence per share.
The unaudited ex-income NAV of TEMIT as at 13 April 2021 was £2579.969m, representing a NAV of 1092.07 pence per share.

In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,
including accumulated or accrued income, and using bid price information relating to the underlying assets.
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.

The NAV of TEMIT is calculated daily at US close of markets using the latest available closing bid prices in each market of investment. However, where appropriate,
these prices are adjusted to a fair value basis having regard to a range of market triggers and proxies.

For information purposes only, if fair value at yesterday's US close had not been applied,
The unadjusted cum-income NAV would have been, £2601.075m, representing a NAV of 1101.00 pence per share.
and the unadjusted ex-income NAV would have been, £2570.544m, representing a NAV of 1088.08 pence per share.
Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.

If debt were valued at cost, the cum-income NAV would increase by 0.94p

For information please contact Client Dealer Services on freephone 0800 305 306.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.